Teradyne beats Q3 revenue, adjusted EPS estimates on AI-related test demand

Reuters
10/29
Teradyne beats Q3 revenue, adjusted EPS estimates on AI-related test demand

Overview

  • Semiconductor testing tools maker Teradyne Q3 revenue rises 4% yr/yr to $769 mln, beating analyst expectations

  • Adjusted EPS for Q3 beats consensus, driven by Semiconductor Test performance

  • Company expects Q4 revenue to rise 25% sequentially, driven by AI demand

Outlook

  • Teradyne expects Q4 2025 revenue between $920 mln and $1,000 mln

  • Company forecasts Q4 2025 GAAP EPS of $1.12 to $1.39

  • Teradyne anticipates Q4 2025 non-GAAP EPS of $1.20 to $1.46

Result Drivers

  • SEMICONDUCTOR TEST - Strong performance in Semiconductor Test, especially in System-on-a-Chip solutions for AI applications, drove Q3 results

  • AI DEMAND - Robust AI-related demand in compute, networking, and memory segments expected to continue into Q4

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

$769 mln

$743.77 mln (14 Analysts)

Q3 Adjusted EPS

Beat

$0.85

$0.78 (15 Analysts)

Q3 EPS

$0.75

Q3 Adjusted Net Income

Beat

$135.90 mln

$124.17 mln (12 Analysts)

Q3 Net Income

$119.60 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy", 6 "hold" and 3 "sell" or "strong sell"

  • The average consensus recommendation for the semiconductor equipment & testing peer group is "buy."

  • Wall Street's median 12-month price target for Teradyne Inc is $135.00, about 9.3% below its October 27 closing price of $147.50

  • The stock recently traded at 34 times the next 12-month earnings vs. a P/E of 23 three months ago

Press Release: ID:nBw7VMCXna

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10